New england biolabs:1105931 [25-000749] 01-nebnext globin & rrna depletion kit (human/mouse/RAT) 96 reactions 02-nebnext multiplex oligos for illumina (96 index primers) 03-nebnext rrna depletion…
Ended Awarded
- Contract number
- 75N92B25F90004
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,760
Award facts
- Contract value 100% obligated
- $12,760.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was made by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to New England Biolabs, Inc. (NEB), a for-profit manufacturer of goods. The contract has a ceiling value of $12,760.00 and is a Blanket Purchase Agreement (BPA) call order under a larger $10,000,000 BPA awarded to NEB by the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations.
The contract is for the supply of various NEB molecular biology products, including the NEBNext Globin & rRNA Depletion Kit, NEBNext Multiplex Oligos for Illumina, and NEBNext rRNA Depletion Kit, which are used in genomics research, infectious disease studies, and other biomedical investigations across federal agencies. NEB has a track record of successfully fulfilling contracts and grants from NIH, Centers for Disease Control and Prevention, National Oceanic and Atmospheric Administration, and Federal Bureau of Investigation. This award does not have a set-aside designation.
Description
New england biolabs:1105931 [25-000749] 01-nebnext globin & rrna depletion kit (human/mouse/RAT) 96 reactions 02-nebnext multiplex oligos for illumina (96 index primers) 03-nebnext rrna depletion kit (human/mouse/RAT)
Quick answers
Who was awarded contract 75N92B25F90004?
75N92B25F90004 was awarded to New England Biolabs, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on December 11, 2024.
How much is contract 75N92B25F90004 worth?
The government has obligated $12,760 on 75N92B25F90004.
Is contract 75N92B25F90004 an order under another contract?
Yes. 75N92B25F90004 is a BPA call under 75N98024A00061, a blanket purchase agreement.
Was contract 75N92B25F90004 competed?
The extent of competition for 75N92B25F90004 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award